NCT02123732View on ClinicalTrials.gov

Role of DbXell in the Treatment of Subjects With Mildly Uncontrolled Type 2 Diabetes Mellitus

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

February 28, 2017

Conditions
Type 2 Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

DbXell

DIETARY_SUPPLEMENT

Placebo

Trial Locations (1)

42150

Laniado Hospital, Diabetes Unit, Netanya

Sponsors

Collaborators (1)

KGS Research
All Listed Sponsors
collaborator

KGS Research

OTHER

lead

Laniado Hospital

OTHER